The Next Generation Bittium OmegaSnap™ ECG Electrode Enables Long-term ECG Recordings -- MEDICA - World Forum for Medicine

20/01/2021

Bittium Biosignals Oy

The Next Generation Bittium OmegaSnap™ ECG Electrode Enables Long-term ECG Recordings

Oulu, Finland, January 20, 2021 – Bittium, a leading specialist for secure communications, connectivity, and medical technology solutions, launches next-generation Bittium OmegaSnap™ ECG Electrode for the Bittium Faros™ ECG sensors. Bittium OmegaSnap™ is a wearable ECG patch electrode specifically designed for long term ECG recordings. The new electrode is based on the popular Bittium FastFix™ electrode, which has been further developed into an even more user-friendly shape based on the feedback received from our customers, without compromising the excellent signal quality. Additionally, environmental friendliness has been taken into account in the design by reducing the amount of plastic used in an electrode.

Bittium OmegaSnap™ ECG Electrode connects to the Bittium Faros™ sensor through a new reusable Bittium OmegaSnap™ Adapter. The lightweight and discreet adapter makes it easier to place the electrode on a patient without a Faros sensor attached to it. The adapter also allows the Faros sensor to be temporarily detached from the patch electrode. In the case of remote monitoring, such as the Bittium HolterPlus™ solution, it significantly enhances the long-term use of the sensor, for example, when charging.

The biocompatible materials and adhesives used in the new Bittium OmegaSnap™ electrode are commonly used in the healthcare industry, making the patches well suited for continuous long-term ECG measurements (up to 7 days). The electrode's flexible structure allows for larger chest movements and moving freely during sleep, daily chores, or when exercising.

"We are extremely proud of our new OmegaSnap™ electrode," says Arto Pietilä, Senior Vice President of Bittium Medical Technologies.  "Excellent anatomical fit and signal quality, extended wear time, and improved usability will take ECG measurements to a whole new level."

Bittium OmegaSnap™ ECG Electrode will be available during the first quarter of 2021. The sales package contains 50 Bittium OmegaSnap™ electrodes and one Bittium OmegaSnap™ adapter. The adapters are also available separately as accessories. For more information, please contact our sales at medical@bittium.com or from our website at www.bittium.com/medical .

Further information:

Arto Pietilä
Senior Vice President, Medical Technologies
Tel. +358 (0)40 3443507
 

Distribution:

Main media

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions, leveraging its 35 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. In the field of healthcare technology, Bittium offers solutions for the measurement and monitoring of biosignals in the areas of cardiology, neurophysiology, rehabilitation, occupational health, and sports medicine. Net sales in 2019 were EUR 75.2 million, and operating profit was EUR 6.3 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com

Exhibitor Data Sheet